Gilles A. Robichaud

1.2k total citations
53 papers, 927 citations indexed

About

Gilles A. Robichaud is a scholar working on Molecular Biology, Immunology and Cancer Research. According to data from OpenAlex, Gilles A. Robichaud has authored 53 papers receiving a total of 927 indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Molecular Biology, 10 papers in Immunology and 9 papers in Cancer Research. Recurrent topics in Gilles A. Robichaud's work include MicroRNA in disease regulation (7 papers), HIV Research and Treatment (6 papers) and Circular RNAs in diseases (6 papers). Gilles A. Robichaud is often cited by papers focused on MicroRNA in disease regulation (7 papers), HIV Research and Treatment (6 papers) and Circular RNAs in diseases (6 papers). Gilles A. Robichaud collaborates with scholars based in Canada, United States and Switzerland. Gilles A. Robichaud's co-authors include Rodney J. Ouellette, Sami Benzina, Michel J. Tremblay, Pier Morin, Miroslava Čuperlović‐Culf, Nicolas Crapoulet, Jean-François Fortin, Benoı̂t Barbeau, Mohamed Touaibia and Ehsan Gharib and has published in prestigious journals such as Nucleic Acids Research, Journal of Biological Chemistry and Blood.

In The Last Decade

Gilles A. Robichaud

50 papers receiving 905 citations

Peers

Gilles A. Robichaud

IMMUN

VIROL

ONCOL

Yin Sun China

Biswanath Majumder India

Deborah C. Melder United States

Ju Bao United States

Alexandre E. Nowill Brazil

Amit Kulkarni United States

Wiweka Kaszubska United States

Jay Chauhan United States

Yingli Cao China

Deepa Nath India

Yin Sun China

Gilles A. Robichaud

426 ×0.8

170 ×0.8

241 ×1.4

IMMUN

108 ×0.9

VIROL

130 ×1.2

ONCOL

Citations per year, relative to Gilles A. Robichaud Gilles A. Robichaud (= 1×) peers Yin Sun

Countries citing papers authored by Gilles A. Robichaud

Since Specialization

Citations

This map shows the geographic impact of Gilles A. Robichaud's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gilles A. Robichaud with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gilles A. Robichaud more than expected).

Fields of papers citing papers by Gilles A. Robichaud

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gilles A. Robichaud. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gilles A. Robichaud. The network helps show where Gilles A. Robichaud may publish in the future.

Co-authorship network of co-authors of Gilles A. Robichaud

This figure shows the co-authorship network connecting the top 25 collaborators of Gilles A. Robichaud. A scholar is included among the top collaborators of Gilles A. Robichaud based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gilles A. Robichaud. Gilles A. Robichaud is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Pichaud, Nicolas, et al.. (2023). Mitochondria Transfer by Platelet-Derived Microparticles Regulates Breast Cancer Bioenergetic States and Malignant Features. Molecular Cancer Research. 22(3). 268–281. 15 indexed citations

Robichaud, Gilles A., et al.. (2023). Neurological manifestations of post-acute sequelae of COVID-19: which liquid biomarker should we use?. Frontiers in Neurology. 14. 1233192–1233192. 7 indexed citations

Robichaud, Gilles A., et al.. (2023). Reactive gliosis and neuroinflammation: prime suspects in the pathophysiology of post-acute neuroCOVID-19 syndrome. Frontiers in Neurology. 14. 1221266–1221266. 5 indexed citations

Robichaud, Gilles A., et al.. (2023). Reactive gliosis and neuroinflammation as prime suspects in neuropasc pathophysiology. Journal of the Neurological Sciences. 455. 122575–122575. 1 indexed citations

Gharib, Ehsan, et al.. (2023). Circular RNA Expression Signatures Provide Promising Diagnostic and Therapeutic Biomarkers for Chronic Lymphocytic Leukemia. Cancers. 15(5). 1554–1554. 5 indexed citations

Gharib, Ehsan, et al.. (2023). Platelet-derived microparticles provoke chronic lymphocytic leukemia malignancy through metabolic reprogramming. Frontiers in Immunology. 14. 1207631–1207631. 17 indexed citations

Gharib, Ehsan, et al.. (2021). Pax-5 Protein Expression Is Regulated by Transcriptional 3′UTR Editing. Cells. 11(1). 76–76. 5 indexed citations

Middelveen, Marianne J., et al.. (2021). Dermatological and Genital Manifestations of Lyme Disease Including Morgellons Disease. Clinical Cosmetic and Investigational Dermatology. Volume 14. 425–436. 5 indexed citations

Crapoulet, Nicolas, et al.. (2018). Pax-5 Inhibits NF-κB Activity in Breast Cancer Cells Through IKKε and miRNA-155 Effectors. Journal of Mammary Gland Biology and Neoplasia. 23(3). 177–187. 15 indexed citations

10.

Crapoulet, Nicolas, et al.. (2018). Pax-5 Inhibits Breast Cancer Proliferation Through MiR-215 Up-regulation. Anticancer Research. 38(9). 5013–5026. 25 indexed citations

11.

Benzina, Sami, et al.. (2016). Breast Cancer Malignant Processes are Regulated by Pax-5 Through the Disruption of FAK Signaling Pathways. Journal of Cancer. 7(14). 2035–2044. 14 indexed citations

12.

Jean, Stéphanie, et al.. (2015). Mammaglobin 1 promotes breast cancer malignancy and confers sensitivity to anticancer drugs. Molecular Carcinogenesis. 55(7). 1150–1162. 14 indexed citations

13.

Ouellette, Rodney J., et al.. (2014). Intracellular Expression of Inflammatory Proteins S100A8 and S100A9 Leads to Epithelial-mesenchymal Transition and Attenuated Aggressivity of Breast Cancer Cells. Anti-Cancer Agents in Medicinal Chemistry. 14(1). 35–45. 24 indexed citations

14.

Benzina, Sami, et al.. (2014). Deoxypodophyllotoxin Isolated from Juniperus communis Induces Apoptosis in Breast Cancer Cells. Anti-Cancer Agents in Medicinal Chemistry. 15(1). 79–88. 46 indexed citations

15.

Crapoulet, Nicolas, et al.. (2011). Coordinated Expression of Pax-5 and FAK1 in Metastasis. Anti-Cancer Agents in Medicinal Chemistry. 11(7). 643–649. 12 indexed citations

16.

Robichaud, Gilles A., Jonathan Perreault, & Rodney J. Ouellette. (2008). Development of an isoform-specific gene suppression system: the study of the human Pax-5B transcriptional element. Nucleic Acids Research. 36(14). 4609–4620. 21 indexed citations

17.

Ryckman, Carle, Gilles A. Robichaud, Jocelyn Roy, et al.. (2002). HIV-1 Transcription and Virus Production Are Both Accentuated by the Proinflammatory Myeloid-Related Proteins in Human CD4+ T Lymphocytes. The Journal of Immunology. 169(6). 3307–3313. 48 indexed citations

18.

Robichaud, Gilles A., Benoı̂t Barbeau, Jean-François Fortin, David M. Rothstein, & Michel J. Tremblay. (2002). Nuclear Factor of Activated T Cells Is a Driving Force for Preferential Productive HIV-1 Infection of CD45RO-expressing CD4+ T Cells. Journal of Biological Chemistry. 277(26). 23733–23741. 34 indexed citations

19.

Barbeau, Benoı̂t, et al.. (2001). Negative Regulation of the NFAT1 Factor by CD45: Implication in HIV-1 Long Terminal Repeat Activation. The Journal of Immunology. 167(5). 2700–2713. 15 indexed citations

20.

Robichaud, Gilles A. & Louise Poulin. (2000). HIV Type 1 nef Gene Inhibits Tumor Necrosis Factor α-Induced Apoptosis and Promotes Cell Proliferation through the Action of MAPK and JNK in Human Glial Cells. AIDS Research and Human Retroviruses. 16(18). 1959–1965. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact